Lipid-based nanoparticles via nose-to-brain delivery: A mini review

Y Xinchen, T Jing, G Jiaoqiong - Frontiers in Cell and Developmental …, 2023 - frontiersin.org
Central nervous system disorders significantly affect the lives and health of millions of
people worldwide. Despite many therapeutic drugs are available that could potentially target …

Improving the biological activities of astaxanthin using targeted delivery systems

L Cai, M Gan, JM Regenstein… - Critical Reviews in Food …, 2024 - Taylor & Francis
The antioxidant and anti-inflammatory properties of astaxanthin (AST) enable it to protect
against oxidative stress-related and inflammatory diseases with a range of biological effects …

Technological Strategies Applied to Pharmaceutical Systems for Intranasal Administration of Drugs Intended for Neurological Treatments: A Review

MVG Botan, JB da Silva, ML Bruschi - AAPS PharmSciTech, 2024 - Springer
The complexity of treating neurological diseases has meant that new strategies have had to
be developed to deliver drugs to the brain more efficiently and safely. Intranasal drug …

Detection of immunogenic cell death after oncolytic virotherapy of glioblastomas

JL Rüttinger - 2024 - ub01.uni-tuebingen.de
Glioblastoma (GBM) is the most common primary malignant brain tumour in adults. With a
median survival time of less than 20 months, it remains incurable, mostly due to its highly …

[引用][C] Lipid-based nanoparticles via nose-to-brain delivery: a mini

Y Xinchen, T Jing, G Jiaoqiong - 2023 - europepmc.org
Central nervous system disorders are a subset of neurological illnesses affecting the
structure or function of the brain and spiral cord. These disorders mainly include …